Nordea Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33B Sell
1,461,892
-18,085
-1% -$18.3M 1.24% 8
2025
Q4
$1.59B Buy
1,479,977
+109,980
+8% +$105M 1.37% 8
2025
Q3
$996M Buy
1,369,997
+75,606
+6% +$56.3M 0.87% 19
2025
Q2
$1.01B Buy
1,294,391
+77,020
+6% +$59.9M 0.94% 17
2025
Q1
$980M Buy
1,217,371
+63,021
+5% +$52.4M 1.03% 13
2024
Q4
$887M Buy
1,154,350
+138,835
+14% +$115M 0.93% 16
2024
Q3
$893M Buy
1,015,515
+97,259
+11% +$87.4M 1.01% 14
2024
Q2
$838M Buy
918,256
+140,669
+18% +$113M 0.98% 16
2024
Q1
$612M Buy
777,587
+257
+0% +$183K 0.72% 27
2023
Q4
$455M Sell
777,330
-30,653
-4% -$17.9M 0.58% 40
2023
Q3
$435M Buy
807,983
+126,143
+19% +$65M 0.6% 37
2023
Q2
$318M Buy
681,840
+327,875
+93% +$138M 0.44% 62
2023
Q1
$121M Buy
353,965
+38,894
+12% +$13.1M 0.18% 144
2022
Q4
$115M Sell
315,071
-10,887
-3% -$3.86M 0.18% 147
2022
Q3
$106M Sell
325,958
-37,965
-10% -$12M 0.17% 148
2022
Q2
$118M Buy
363,923
+20,550
+6% +$6.17M 0.17% 149
2022
Q1
$99.8M Buy
343,373
+9,184
+3% +$2.36M 0.13% 177
2021
Q4
$92.9M Sell
334,189
-318,364
-49% -$80.7M 0.11% 193
2021
Q3
$154M Sell
652,553
-2,106
-0.3% -$520K 0.2% 136
2021
Q2
$150M Sell
654,659
-766,575
-54% -$154M 0.2% 136
2021
Q1
$263M Sell
1,421,234
-183,200
-11% -$35.8M 0.38% 69
2020
Q4
$271M Buy
1,604,434
+90,966
+6% +$13.6M 0.44% 59
2020
Q3
$220M Sell
1,513,468
-1,430,716
-49% -$221M 0.41% 59
2020
Q2
$480M Buy
2,944,184
+1,443,527
+96% +$222M 0.5% 53
2020
Q1
$203M Sell
1,500,657
-25,737
-2% -$3.54M 0.49% 54
2019
Q4
$200M Buy
1,526,394
+148,693
+11% +$17.2M 0.4% 64
2019
Q3
$156M Buy
1,377,701
+448,122
+48% +$49.9M 0.34% 75
2019
Q2
$103M Buy
929,579
+256,341
+38% +$30.2M 0.23% 95
2019
Q1
$87.4M Buy
673,238
+173,346
+35% +$21.1M 0.18% 110
2018
Q4
$57.8M Buy
499,892
+81,615
+20% +$9.12M 0.14% 134
2018
Q3
$44.9M Buy
418,277
+1,674
+0.4% +$167K 0.09% 168
2018
Q2
$35.5M Sell
416,603
-62,075
-13% -$5.1M 0.09% 166
2018
Q1
$37M Buy
478,678
+26,598
+6% +$2.14M 0.09% 157
2017
Q4
$38.2M Buy
452,080
+2,085
+0.5% +$177K 0.09% 152
2017
Q3
$38.5M Buy
449,995
+18,197
+4% +$1.49M 0.09% 152
2017
Q2
$35.5M Sell
431,798
-10,686
-2% -$872K 0.09% 149
2017
Q1
$37.2M Sell
442,484
-135,461
-23% -$10.8M 0.1% 141
2016
Q4
$42.5M Sell
577,945
-628,730
-52% -$46.8M 0.11% 139
2016
Q3
$96.8M Buy
1,206,675
+15,944
+1% +$1.28M 0.25% 91
2016
Q2
$93.8M Buy
1,190,731
+89,851
+8% +$6.76M 0.26% 86
2016
Q1
$79.3M Buy
1,100,880
+80,677
+8% +$6.1M 0.24% 100
2015
Q4
$86M Buy
1,020,203
+92,778
+10% +$7.7M 0.29% 87
2015
Q3
$77.6M Buy
927,425
+17,133
+2% +$1.45M 0.29% 88
2015
Q2
$76M Sell
910,292
-551,237
-38% -$42M 0.27% 99
2015
Q1
$106M Sell
1,461,529
-314,775
-18% -$22.4M 0.38% 75
2014
Q4
$123M Buy
1,776,304
+49,628
+3% +$3.35M 0.45% 61
2014
Q3
$112M Buy
1,726,676
+87,743
+5% +$5.56M 0.45% 59
2014
Q2
$102M Buy
1,638,933
+56,249
+4% +$3.36M 0.43% 64
2014
Q1
$93.2M Sell
1,582,684
-29,209
-2% -$1.63M 0.43% 56
2013
Q4
$82.2M Buy
1,611,893
+223,704
+16% +$11.2M 0.41% 62
2013
Q3
$69.9M Buy
1,388,189
+389,621
+39% +$20.4M 0.39% 67
2013
Q2
$49M Buy
+998,568
New +$54.3M 0.3% 81

Other funds holding LLY

Nordea Investment Management's LLY Position: Q1 2026 in Review

Nordea Investment Management reduced its Eli Lilly (LLY) stake by 1.2% in Q1 2026, selling an estimated $18.3M and leaving 1,461,892 shares worth $1.33B. The position accounts for 1.24% of the portfolio, ranked #8.

Nordea Investment Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.59B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Nordea Investment Management held 1,461,892 shares of Eli Lilly worth $1.33B as of Q1 2026.
  • Nordea Investment Management sold 18,085 Eli Lilly shares in Q1 2026, an estimated $18.3M.
  • Eli Lilly made up 1.24% of Nordea Investment Management's portfolio in Q1 2026, its #8 holding.
  • Nordea Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Nordea Investment Management's Eli Lilly position peaked at $1.59B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.